View all cases
UPC CFI 617/2025
Jul 9, 2025·EP2279254 · NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
- Case details
- StatusCase ClosedActionCounterclaim for revocationCategoryCounterclaim for revocation
- Parties
- Respondents
- Arbutus Biopharma CorporationOperating co.
Representatives- Koen Bijvank-Brinkhof
- Lilia Bouzoraa
- Eveline Lots-Brinkhof
- Hendrik Lambers-Vossius & Brinkhof UPC Litigators
- Mark van Gardingen
- Division
- The Hague LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Merck Sharp & Dohme CorporationAdmissible2018-04-05
- Moderna Therapeutics, Inc.Admissible2018-04-05
- Merck Sharp & Dohme LLCWithdrawn2018-04-05
- ModernaTX, Inc.Withdrawn2018-04-05
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| The Hague LD | Locked | Locked |
| Judge Edger Brinkman | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Samuel Granata | Locked | Locked |
| Judge Xavier Dorland-Galliot | Locked | Locked |
At the UPC: Moderna Group (20 cases)·Arbutus Biopharma Corporation (12 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 3 other proceedings
1 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
Documents
Show all 224 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-08-25 | Not public |
| Order | 2026-08-25 | Not public |
| Order | 2026-08-25 | Not public |
| Receipt | 2026-03-04 | Not public |
| Cover sheet | 2026-03-04 | Not public |
| Application document Defendant | 2026-03-04 | Not public |
| Receipt | 2026-02-25 | Not public |
| Cover sheet | 2026-02-25 | Not public |
| Receipt | 2026-02-25 | Not public |
| Cover sheet | 2026-02-25 | Not public |